US5496828A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods of inhibiting ulcerative mucositis
Assignee: Eli Lilly and Co
•
Filing: 1994-08-22
•
Granted: 1996-03-05
•
Expires: 2014-08-22
Abstract
Abstract A method of inhibiting ulcerative mucositis comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R 1 and R 3 are independently hydrogen, --CH 3 , ##STR2## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Inventors
- 👤 George J. Cullinan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:29
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61K31/4523; A61K31/4535; A61K31/40; A61K31/4025; A61K31/55; A61P; A61P1/00; A61P1/02; A61P29/00
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
68 words
A method of inhibiting radiation or chemotherapy induced ulcerative mucositis comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR5## wherein R 1 and R 3 are independently hydrogen, --CH 3 , ##STR6## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine, hexamethylenemino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Claim 2
Independent Claim
68 words
A method of inhibiting radiation or chemotherapy induced ulcerative mucositis comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR5## wherein R 1 and R 3 are independently hydrogen, --CH 3 , ##STR6## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine, hexamethylenemino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Claim 3
Dependent Claim
13 words
The method of claim 1 wherein said compound is the hydrochloride salt thereof.
Claim 4
Dependent Claim
14 words
The method of claim 1 wherein said compound is ##STR7## or its hydrochloride salt.
Claim 5
Dependent Claim
11 words
The method of claim 1 wherein said ulcerative mucositis is oral.
Claim 6
Dependent Claim
14 words
The method of claim 1 wherein said ulcerative mucositis is induced by cancer therapy.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-03-05 | 1999-09-04 | 2000-03-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-03-05 | 2003-09-04 | 2004-03-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-03-05 | 2007-09-04 | 2008-03-05 | $7700.00 | Window Closed / Lapsed |